Sickle cell disease (SCD) is a group of genetic conditions related to the presence of a sickle hemoglobin (Hb S) mutation (HBB:c.20A\>T). People with SCD can be homozygous for Hb S or can have compound heterozygosity for Hb S with other gene mutations.[@bib0210], [@bib0215] Some hematologic features of SCD are listed in [Table 1](#tbl0005){ref-type="table"}, but rare genotypes can also be found. Since the concentration of Hb S is a pathophysiological factor of disease severity, the presence of lower concentrations of Hb S due to double heterozygosity can determine phenotypic heterogeneity.[@bib0210], [@bib0220] However, other genetic and environmental factors can also have an effect on the disease phenotype.[@bib0225]

Studies looking for abnormal hemoglobins (Hbs) in the Brazilian population have been performed since the 1950s.[@bib0230], [@bib0235], [@bib0240], [@bib0245] However, the Brazilian Government Directive MS \# 822/01 that regulates newborn screening for hemoglobinopathies, has promoted an increase of data about hemoglobinopathies in different Brazilian regions.[@bib0250], [@bib0255], [@bib0260] This associated with the use of isoelectric focusing electrophoresis (IEF) and high-pressure liquid chromatography (HPLC) as diagnostic methods, has enabled the identification of an increasing number of abnormal Hbs as well as compound heterozygous states of Hb S.[@bib0265], [@bib0270], [@bib0275] An example is a paper published in this issue of the Revista Brasileira de Hematologia e Hemoterapia that shows data on a cohort of children with hemoglobin SD pattern.[@bib0280]

Hb D is an abnormal Hb, which migrates to the same position as Hb S in electrophoresis at alkaline pH, and can be separated from Hb S in acid pH.[@bib0285], [@bib0290], [@bib0295] Several Hb D have been described in different racial groups, but the majority presented a point mutation in codon 121 of the β-globin gene, which results in the substitution of glutamic acid for glutamine (HBB:c.364G\>C). This abnormal Hb is usually called Hb D-Punjab or Hb D-Los Angeles, however it can also be named Hb D-North Carolina, Hb D-Chicago, Hb D-Portugal, Hb D-Cyprus, and Hb D-Oak Ridge.[@bib0300], [@bib0305], [@bib0310] The estimated prevalence of Hb D-Punjab is 0.1 to 0.4% in African-Americans.[@bib0315] In Brazil, a study of African descendants showed a similar prevalence.[@bib0230]

Sometime after the discovery of Hb D-Punjab, the coinheritance of Hb D-Punjab and Hb S was identified in Caucasian patients with clinical and hematological manifestations similar to those of sickle cell anemia (SCA), because this mutation facilitates Hb S polymerization.[@bib0320], [@bib0325], [@bib0330] Further clinical studies confirmed the severity of the manifestations of this association and the need to treat these individuals as SCA patients by prescribing hydroxyurea when indicated.[@bib0310], [@bib0335], [@bib0340], [@bib0345], [@bib0350]

There are other types of Hb D due to different point mutations in the β-globin gene, such as Hb D-Iran (HBB:c.67G\>C) and Hb D-Ibadan (HBB:c.263C\>A). However, individuals with these mutations have normal hematologic values and do not suffer from vaso-occlusive complications, since their red cells do not sickle under physiologic conditions.[@bib0295], [@bib0355], [@bib0360]

Hb Korle-Bu (Hb KB) or Hb G-Accra (HBB:c.220G\>A) is a frequent mutation in Sub-Saharan Africa.[@bib0365], [@bib0370] This Hb has the same IEF mobility as Hb D-Punjab but can be differentiated by HPLC. Heterozygotes for Hb KB have no hematologic alterations, and individuals with double heterozygosis Hb S-Hb KB have normal red cells on blood smear and a benign clinical course, similar to sickle cell trait as Hb KB does not participate in the gelation of Hb S.[@bib0370], [@bib0375]

Interestingly, the Hb KB mutation \[beta73(E17)Asp→Asn\] can occur in addition to the Hb S mutation \[beta6(A3)Glu6Val\] in the same beta globin chain. In this case, this Hb with a double mutation is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A\>T, HBB:c.220G\>A), because it migrates to the position of Hb C in cellulose acetate electrophoresis at alkaline pH. Individuals heterozygous for Hb C-Harlem are asymptomatic, but the coinheritance of Hb S and Hb C-Harlem has clinical manifestations similar to SCA.[@bib0305], [@bib0365], [@bib0380]

Researchers from India and the Middle East are the main authors of the few papers about Hb SD-Punjab; there are less data published about the association Hb S-Hb KB.[@bib0310], [@bib0340], [@bib0345], [@bib0350], [@bib0375], [@bib0385], [@bib0390], [@bib0395], [@bib0400], [@bib0405], [@bib0410] By studying two different groups of patients with Hb SD patterns, specifically Hb SD-Punjab and Hb S-Hb KB, Rezende et al. not only published important clinical data about the coinheritance of two rare Hb but also pointed out the importance of this differential diagnosis.[@bib0280]
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Hematological features of some sickle hemoglobinopathies.

Table 1

  Genotype             PCV (%)   Retic (%)   MCV (fL)   Hb F (%)   Hb A~2~ (%)   \% Variant           Severity[a](#tblfn0005){ref-type="table-fn"}
  -------------------- --------- ----------- ---------- ---------- ------------- -------------------- ----------------------------------------------
  SCA                  25        8           90         5          3             \>90% Hb S           ++++
  Hb SC disease        35        3           80         2          3             50% Hb S, 50% Hb C   ++
  S-β^0^ thalassemia   27        7           82         7          5             90% Hb S             ++++
  S-β^+^ thalassemia   38        2           70         2          6             5--30% Hb A          ++
  SCA-α thalassemia    30        6           78         5          5             \>90% Hb S           +++
  Hb SE disease        35        3           75         2          3             ∼30% Hb E            ++
  Hb SD disease\*      20                    86         1--10      2--4          45% Hb S, 45% Hb D   +++
  Sickle cell trait    45        1           85         1          2             60% Hb A, 40% Hb S   ![](fx1.gif)

SCA: sickle cell anemia; PCV: packed cell volume; Retic: reticulocyte count; MCV: mean cell volume; Hb: Hemoglobin.

Severity of disease rated from most severe (++++) to absence of clinical events (![](fx1.gif)) includes complications related to sickle vaso-occlusion and hemolysis.

Table modified from [@bib0210] with \* data obtained from [@bib0310], [@bib0340], [@bib0365].
